期刊简介

               1977年创刊,中华人民共和国卫生部主管,中华医学会、中国医学科学院放射医学研究所主办。本刊是《国际医学》系列期刊之一,结合国内实际情况主要介绍国内外在放射医学与核医学两大领域中的新动态、新进步、新技术和新经验的国家级学术性、信息性杂志,以促进我国放射医学与核医学研究工作的发展。                

首页>国际放射医学核医学杂志
  • 杂志名称:国际放射医学核医学杂志
  • 主管单位:中华人民共和国国家卫生和计划生育委员会
  • 主办单位:中华医学会 中国医学科学院放射医学研究所
  • 国际刊号:1673-4114
  • 国内刊号:12-1381/R
  • 出版周期:
期刊荣誉:1999-2000年被天津市期刊质量评估为一级期刊期刊收录:
国际放射医学核医学杂志2016年第02期

HPV16 E6/E7 Negatively Affect Radiosensitivity of Lung Cancer Cells

Lu Lu;Qinghui Meng;Ming Cui;Xiaofei Chu;Shuyi Zhao;Huiwen Xiao;Jiali Dong

关键词:Papillomavirus, human, lung neoplasms, Radiosensitivity, ERK1/2 and AKT, ROS
摘要:Objective Lung cancer cells associated with radioresistance are likely to give rise to local recurrence and distant metastatic relapse,but little is known about its underlying mechanisms.In the present paper,the effects of the HPV16 E6 and HPV16 E7 oncoprotein on the radiosensitivity of lung cancer cell lines were investigated.Methods The HPV16 E6 or HPV16 E7 oncoprotein was expressed by a transient transfection with pcDNA3-HPV16 E6 or pcDNA3-HPV16 E7 expression vector.Human lung cancer H2179 cells and mouse lung cancer Lewis cells were exposed to a γ-ray radiation source,cellular survival was evaluated by using a colony formation assay.The expression of HPV16 oncoproteins E6/E7,extracellular signal-regulated kinases 1/2(ERK1/2) and AKT signaling was determined by Western blot assay.VEGF secretion was determined by ELISA.Results Both HPV16 oncoproteins E6 and E7 significantly decreased radiosensitivity of H2179 cells,associated with a promotion of the ERK1/2 and AKT phosphorylation.A decrease of reactive oxygen species(ROS) and an increase of VEGF levels were observed in the cells expressing the HPV16 oncoproteins E6 and E7.Furthermore,a similar reduction of radiosensitivity mediated by the HPV16 oncoproteins E6 and E7 was also observed in a mouse lung cancer Lewis cells.Conclusion The findings indicate that the HPV16 oncoproteins E6 and E7 negatively affects susceptibility of lung cancer cells to radiotherapy via regulation of the ERK1/2 and Akt signaling pathway and VEGF expression.